
Delivering Benefits for Patients and health systems through value added medicines [Promoted content]
James Burt, Chair of the Value Added Medicines Sector Group at Medicines for Europe shares his vision how off-patent innovation can help sustainably address today’s major public health needs such as antimicrobial resistance, cardiovascular […]